SCHEMBL141928

SCHEMBL141928

CN(C)CCCNCCO

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.62
PAOX Q6QHF9 1/20 0.55
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 1/20 0.48
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
DPP7 Q9UHL4 2/20 0.44
TSHR P16473 1/20 0.43
ALOX15 P16050 2/20 0.40
DNM1 Q05193 2/20 0.38
PRMT3 O60678 1/20 0.38
CARM1 Q86X55 1/20 0.38
PRMT6 Q96LA8 1/20 0.38
PRMT1 Q99873 1/20 0.38
PRMT8 Q9NR22 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7893139 0.97 TDP1 (0.60) TDP1PAOXCYP2C9CYP2C19MAPT
SCHEMBL17493166 0.95 TDP1 (0.58) TDP1PAOXCYP2C9CYP2C19MAPT
SCHEMBL11441671 0.90 TDP1 (0.62) TDP1PAOXCYP2C9CYP2C19MAPT
Diethanolamine SCHEMBL23648063 0.89 MAPT (0.53) TDP1PAOXCYP2C9CYP2C19MAPT
SCHEMBL15859 0.89 TDP1 (0.75) TDP1PAOXCYP2C9CYP2C19MAPT
SCHEMBL863534 0.86
Ammonia Solution, Strong SCHEMBL7104676 0.86 TDP1 (0.71) TDP1PAOXCYP2C9CYP2C19MAPT
SCHEMBL26967080 0.86 TDP1 (0.71) TDP1PAOXCYP2C9CYP2C19MAPT
SCHEMBL5131831 0.86 TDP1 (0.71) TDP1PAOXCYP2C9CYP2C19MAPT
SCHEMBL5129514 0.86 TDP1 (0.71) TDP1PAOXCYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 782 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4217362-B1 REDUCTION BY A SILANE IN THE PRESENCE OF ZINC CATALYST FIRMENICH & CIE (CH) 2026-03-18 EP claimed
EP-4667511-A2 DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY Tiba Biotech LLC (US) 2025-12-24 EP claimed
US-20250262589-A1 AMINE COMPOSITION FOR CARBON DIOXIDE SEPARATION USE TOSOH CORPORATION (JP) 2025-08-21 US claimed
WO-2025076244-A1 MOISTURE CURABLE ACRYLIC POLYMER COMPOSITIONS BASF SE (DE) 2025-04-10 WO claimed
EP-4494740-A1 AMINE COMPOSITION FOR CARBON DIOXIDE SEPARATION USE TOSOH CORPORATION (JP) 2025-01-22 EP claimed
US-20240207187-A1 DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY TIBA BIOTECH LLC (US) 2024-06-27 US claimed
US-20240209138-A1 PRODUCTION OF HARD POLYURETHANE OR POLYISOCYANURATE FOAM EVONIK OPERATIONS GMBH (DE) 2024-06-27 US claimed
CN-117661365-B Environment-friendly nanometer negative ion decorative paper and preparation method thereof 江苏佳饰家新材料集团股份有限公司 2024-06-21 CN claimed
CN-117915958-A Dendritic structures as non-viral vectors in gene delivery 蒂巴生物技术有限公司 2024-04-19 CN claimed
CN-117700438-A Silicon phthalocyanine capable of generating hydroxyl free radical through high-efficiency photosensitization and preparation and application thereof 福州大学 2024-03-15 CN claimed
EP-1942130-A2 NOVEL CARBOSILANE DENDRIMERS, PREPARATION METHOD THEREOF AND USE OF SAME Universidad de Alcalá (ES) 2008-07-09 EP claimed
WO-2008030006-A1 AMINE AQUEOUS SOLUTION FOR FORMING AN ACTIVE LAYER OF POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE, POLYAMIDE REVERSE OSMOSIS COMPOSITE MEMBRANE PREPARED THEREBY, AND PREPARATION METHOD THEREOF WOONGJINCOWAY CO, LTD, . (KR) 2008-03-13 WO claimed
CN-101048366-A Hydroxyalkylated polyalkylenepolyamine composition, method for producing same, and method for producing polyurethane resin using same TOSOH CORP (JP) 2007-10-03 CN claimed
EP-1670836-A1 CATALYST SYSTEM FOR PRODUCING DIENE AND VINYL AROMATIC HOMOPOLYMERS AND COPOLYMERS BY ANIONIC POLYMERISATION Hellermann, Walter (DE) 2006-06-21 EP claimed
WO-2005035599-A1 CATALYST SYSTEM FOR PRODUCING DIENE AND VINYL AROMATIC HOMOPOLYMERS AND COPOLYMERS BY ANIONIC POLYMERISATION HELLERMANN WALTER (DE) 2005-04-21 WO claimed
EP-1032428-A2 TREATMENT OF CANCER USING CYTOKINE-EXPRESSING POLYNUCLEOTIDES AND COMPOSITIONS THEREFOR VICAL INCORPORATED (US) 2000-09-06 EP claimed
WO-2000040273-A2 TREATMENT OF VIRAL DISEASES USING AN INTERFERON OMEGA EXPRESSING POLYNUCLEOTIDE VICAL INCORPORATED (US) 2000-07-13 WO claimed
US-6004823-A Compounds SMITHKLINE BEECHAM CORPORATION (US) 1999-12-21 US claimed
WO-1999026663-A2 TREATMENT OF CANCER USING CYTOKINE-EXPRESSING POLYNUCLEOTIDES AND COMPOSITIONS THEREFOR VICAL, INC. (US) 1999-06-03 WO claimed
EP-0319316-A2 Griseolic acid monoesters, their preparation and use SANKYO COMPANY LIMITED (JP) 1989-06-07 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207187-A1 DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY TLR3, TLR9, TLR6 TDP1 1442/4885PAOX 2038/4885CYP2C9 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.